Assessment of optimal size and composition of the US National Registry of Hematopoietic Stem Cell Donors

被引:90
作者
Kollman, C
Abella, E
Baitty, RL
Beatty, PG
Chakraborty, R
Christiansen, CL
Hartzman, RJ
Hurley, CK
Milford, E
Nyman, JA
Smith, TJ
Switzer, GE
Wada, RK
Setterholm, M
机构
[1] Natl Marrow Donor Program, Minneapolis, MN USA
[2] Childrens Hosp Michigan, Div Hematol Oncol, Detroit, MI 48201 USA
[3] Hlth Resources & Serv Adm, Bone Marrow Transplantat Branch, Div Transplantat, Bethesda, MD USA
[4] Montana Canc Specialists, Missoula, MT USA
[5] Univ Cincinnati, Coll Med, Ctr Genome Informat, Dept Environm Hlth, Cincinnati, OH USA
[6] Boston Univ, Ctr Hlth Qual Outcomes & Econ Res, Bedford, MA USA
[7] Boston Univ, Dept Hlth Serv, Bedford, MA USA
[8] Bill Young Marrow Donor Program, Kensington, MD USA
[9] Georgetown Univ, Med Ctr, Dept Oncol, Washington, DC 20007 USA
[10] Brigham & Womens Hosp, Div Renal, Dept Med, Boston, MA 02115 USA
[11] Univ Minnesota, Div Hlth Serv Res & Policy, Sch Publ Hlth, Minneapolis, MN USA
[12] Virginia Commonwealth Univ, Massey Canc Ctr, Dept Med, Richmond, VA USA
[13] Virginia Commonwealth Univ, Massey Canc Ctr, Dept Hlth Adm, Richmond, VA USA
[14] Univ Pittsburgh, Ctr Res Hlth Care, Dept Med, Pittsburgh, PA USA
[15] Univ Hawaii, Canc Etiol Program, Canc Res Ctr Hawaii, Honolulu, HI 96822 USA
关键词
stem cell transplant; donor registry; HLA-match; population genetics; public policy;
D O I
10.1097/01.TP.0000132327.40702.97
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Background. The National Marrow Donor Program (NMDP) receives federal funding to operate a registry of over 4 million volunteer donors for patients in need of a hematopoietic stem cell transplant. Because minority patients are less likely to find a suitably matched donor than whites, special efforts have been aimed toward recruitment of minorities. Significant financial resources are required to recruit and tissue type additional volunteer donors. Methods. Population genetics models have been constructed to project likelihoods of finding a human leukocyte antigen (HLA)-matched donor for patients of various racial/ethnic groups. These projections have been made under a variety of strategies for expansion of the NMDP Registry. Cost-effectiveness calculations incorporated donor unavailability and other barriers to transplantation. Results. At current recruitment rates, the probability of an available HLA-A,B,DRB1 matched donor is projected to increase from 27% to 34%; 45% to 54%; 75% to 79%; and 48% to 55%, for blacks, Asians/Pacific Islanders, whites and Hispanics, respectively, by the year 2007. Substantial increases in minority recruitment would have only modest impacts on these projections. These projections are heavily affected by donor availability rates, which are less than 50% for minority volunteers. Conclusions. Continued recruitment of additional volunteers can improve the likelihood of finding an HLA-matched donor, but will still leave significant numbers of patients of all racial/ethnic groups without a match. Efforts to improve donor availability (especially among minorities) and to increase the number of patients with access to the NMDP Registry may prove to be more cost-effective means of increasing transplants.
引用
收藏
页码:89 / 95
页数:7
相关论文
共 31 条
[11]   MAXIMUM LIKELIHOOD FROM INCOMPLETE DATA VIA EM ALGORITHM [J].
DEMPSTER, AP ;
LAIRD, NM ;
RUBIN, DB .
JOURNAL OF THE ROYAL STATISTICAL SOCIETY SERIES B-METHODOLOGICAL, 1977, 39 (01) :1-38
[12]   ANALYSIS OF 462 TRANSPLANTATIONS FROM UNRELATED DONORS FACILITATED BY THE NATIONAL-MARROW-DONOR-PROGRAM [J].
KERNAN, NA ;
BARTSCH, G ;
ASH, RC ;
BEATTY, PG ;
CHAMPLIN, R ;
FILIPOVICH, A ;
GAJEWSKI, J ;
HANSEN, JA ;
HENSLEEDOWNEY, J ;
MCCULLOUGH, J ;
MCGLAVE, P ;
PERKINS, HA ;
PHILLIPS, GL ;
SANDERS, J ;
STRONCEK, D ;
THOMAS, ED ;
BLUME, KG .
NEW ENGLAND JOURNAL OF MEDICINE, 1993, 328 (09) :593-602
[13]   Non-HLA barriers to unrelated donor stem cell transplantation [J].
Kollman, C ;
Weis, T ;
Switzer, GE ;
Halet, M ;
Kitajima, D ;
Hegland, J ;
Confer, DL .
BONE MARROW TRANSPLANTATION, 2001, 27 (06) :581-587
[14]   Hematopoietic engraftment and survival in adult recipients of umbilical-cord blood from unrelated donors. [J].
Laughlin, MJ ;
Barker, J ;
Bambach, B ;
Koc, ON ;
Rizzieri, DA ;
Wagner, JE ;
Gerson, SL ;
Lazarus, HM ;
Cairo, M ;
Stevens, CE ;
Rubinstein, P ;
Kurtzberg, J .
NEW ENGLAND JOURNAL OF MEDICINE, 2001, 344 (24) :1815-1822
[15]  
LONG JC, 1995, AM J HUM GENET, V56, P799
[16]   RACE, ETHNICITY, CULTURE, AND SCIENCE [J].
MCKENZIE, KJ ;
CROWCROFT, NS .
BRITISH MEDICAL JOURNAL, 1994, 309 (6950) :286-287
[17]  
Mori M, 1996, Biol Blood Marrow Transplant, V2, P134
[18]   HLA gene and haplotype frequencies in the North American population - The National Marrow Donor Program Donor Registry [J].
Mori, M ;
Beatty, PG ;
Graves, M ;
Boucher, KM ;
Milford, EL .
TRANSPLANTATION, 1997, 64 (07) :1017-1027
[19]   The clinical significance of human leukocyte antigen (HLA) allele compatibility in patients receiving a marrow transplant from serologically HLA-A, HLA-B, and HLA-DR matched unrelated donors [J].
Morishima, Y ;
Sasazuki, T ;
Inoko, H ;
Juji, T ;
Akaza, T ;
Yamamoto, K ;
Ishikawa, Y ;
Kato, S ;
Sao, H ;
Sakamaki, H ;
Kawa, K ;
Hamajima, N ;
Asano, S ;
Kodera, Y .
BLOOD, 2002, 99 (11) :4200-4206
[20]   LARGE-SCALE OLIGONUCLEOTIDE TYPING FOR HLA-DRB1/3/4 AND HLA-DQB1 IS HIGHLY ACCURATE, SPECIFIC, AND RELIABLE [J].
NG, J ;
HURLEY, CK ;
BAXTERLOWE, LA ;
CHOPEK, M ;
COPPO, PA ;
HEGLAND, J ;
KUKURUGA, D ;
MONOS, D ;
ROSNER, G ;
SCHMECKPEPER, B ;
YANG, SY ;
DUPONT, B ;
HARTZMAN, RJ .
TISSUE ANTIGENS, 1993, 42 (05) :473-479